The potential deal would be “big and complicated, and I’m still skeptical,” said Jeff Jonas, a portfolio manager at Gabelli Funds, an investor in Walgreens. The company has a lot of debt, which makes a leveraged buyout difficult, he said.
The potential deal would be “big and complicated, and I’m still skeptical,” said Jeff Jonas, a portfolio manager at Gabelli Funds, an investor in Walgreens. The company has a lot of debt, which makes a leveraged buyout difficult, he said.
